Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines

被引：16

作者：

Kim, Sollip ^{[1
]}

Yun, Yeo-Min ^{[2
]}

Chae, Hyo-Jin ^{[3
]}

Cho, Hyun-Jung ^{[4
]}

Ji, Misuk ^{[5
]}

Kim, In-Suk ^{[6
]}

Wee, Kyung-A ^{[7
]}

Lee, Woochang ^{[8
,9
]}

Song, Sang Hoon ^{[10
,11
]}

Woo, Hye In ^{[12
]}

Lee, Soo-Youn ^{[13
]}

Chun, Sail ^{[8
,9
]}

机构：

[1] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Lab Med, Goyang, South Korea

[2] Konkuk Univ, Sch Med, Med Ctr, Dept Lab Med, Seoul, South Korea

[3] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea

[4] Konyang Univ, Coll Med, Konyang Univ Hosp, Dept Lab Med, Daejeon, South Korea

[5] Vet Hlth Serv Med Ctr, Dept Lab Med, Seoul, South Korea

[6] Pusan Natl Univ, Sch Med, Dept Lab Med, Busan, South Korea

[7] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea

[8] Univ Ulsan, Coll Med, Dept Lab Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[9] Asan Med Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[10] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea

[11] Coll Med, Seoul, South Korea

[12] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Lab Med, Chang Won, South Korea

[13] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, 81 Irwon Ro, Seoul 06351, South Korea

来源：

ANNALS OF LABORATORY MEDICINE | 2017年 / 37卷 / 02期

关键词：

Clinical laboratory; Korea; Pharmacogenetics; Testing; Practice guideline; IMPLEMENTATION CONSORTIUM GUIDELINES; THIOPURINE METHYLTRANSFERASE GENOTYPE; DRUG-METABOLIZING-ENZYMES; OF-AMERICAN-PATHOLOGISTS; BREAST-CANCER; GENETIC POLYMORPHISMS; CYP2C19; GENOTYPE; KOREAN PATIENTS; WARFARIN PHARMACOGENETICS; ANTIPLATELET THERAPY;

D O I：

10.3343/alm.2017.37.2.180

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.

引用

页码：180 / 193

页数：14

共 91 条

[1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].

Aithal, GP ;

Day, CP ;

Kesteven, PJL ;

Daly, AK .

LANCET, 1999, 353 (9154) :717-719

[2] Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM) [J].

Albanell, Joan ;

Andreu, Xavier ;

Jose Calasanz, Maria ;

Concha, Angel ;

Maria Corominas, Jose ;

Garcia-Caballero, Tomas ;

Antonio Lopez, Jose ;

Lopez-Rios, Fernando ;

Ramon y Cajal, Santiago ;

Vera-Sempere, Francisco J. ;

Colomer, Ramon ;

Martin, Miguel ;

Alba, Emilio ;

Gonzalez-Martin, Antonio ;

Llombart, Antonio ;

Lluch, Ana ;

Palacios, Jose .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (06) :363-375

[3]

[Anonymous], 2010, LAB MED PRACTICE GUI

[4] Nomenclature for alleles of the thiopurine methyltransferase gene [J].

Appell, Malin L. ;

Berg, Jonathan ;

Duley, John ;

Evans, William E. ;

Kennedy, Martin A. ;

Lennard, Lynne ;

Marinaki, Tony ;

McLeod, Howard L. ;

Relling, Mary V. ;

Schaeffeler, Elke ;

Schwab, Matthias ;

Weinshilboum, Richard ;

Yeoh, Allen E. J. ;

McDonagh, Ellen M. ;

Hebert, Joan M. ;

Klein, Teri E. ;

Coulthard, Sally A. .

PHARMACOGENETICS AND GENOMICS, 2013, 23 (04) :242-248

[5] NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy [J].

Azuma, Junichi ;

Ohno, Masako ;

Kubota, Ryuji ;

Yokota, Soichiro ;

Nagai, Takayuki ;

Tsuyuguchi, Kazunari ;

Okuda, Yasuhisa ;

Takashima, Tetsuya ;

Kamimura, Sayaka ;

Fujio, Yasushi ;

Kawase, Ichiro .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) :1091-1101

[6] HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods [J].

Bartlett, J. M. S. ;

Starczynski, J. ;

Atkey, Neil ;

Kay, E. ;

O'Grady, A. ;

Gandy, Michael ;

Ibrahim, Merdol ;

Jasani, Bharat ;

Ellis, I. O. ;

Pinder, S. E. ;

Walker, R. A. .

JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (08) :649-653

[7] Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics [J].

Becquemont, Laurent ;

Alfrieve, Ana ;

Amstutz, Ursula ;

Brauch, Hiltrud ;

Jacqz-Algrain, Evelyne ;

Laurent-Puig, Pierre ;

Molina, Miguel A. ;

Niemi, Mikko ;

Schwab, Matthias ;

Somogyi, Andrew A. ;

Thervet, Eric ;

Maitland-van der Zee, Anke Hilse ;

van Kuilenburg, Andre B. P. ;

van Schaik, Ron H. N. ;

Verstuyft, Celine ;

Wadelius, Mia ;

Daly, Ann K. .

PHARMACOGENOMICS, 2011, 12 (01) :113-124

[8] Role of Thiopurine Metabolite Testing and Thiopurine Methyltransferase Determination in Pediatric IBD [J].

Benkov, Keith ;

Lu, Ying ;

Patel, Ashish ;

Rahhal, Riad ;

Russell, Gary ;

Teitelbaum, Jonathan .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 56 (03) :333-340

[9]

Benson AB, 2014, COLON CANC VERSION 2

[10] Dependence of Efavirenz- and Rifampicin-Isoniazid-Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia [J].

Bertrand, Julie ;

Verstuyft, Celine ;

Chou, Monidarin ;

Borand, Laurence ;

Chea, Phalla ;

Nay, Kuy Huong ;

Blanc, Francois-Xavier ;

Mentre, France ;

Taburet, Anne-Marie .

JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (03) :399-408

← 1 2 3 4 5 6 7 8 9 10 →